Pronounced long-jev-in-ex
The Official Website
Pronounced long-jev-in-ex
The Official Website
November 7, 2009: by longevinex.com
| Research Studies Conducted With Resveratrol Dietary Supplements | |
| LONGEVINEX® | All 290 Other Brands |
| 2008: Longevinex® reduces inflammation and oxidation better than green tea. Appalachian State University | 2010: Pure Encapsulations 40 mg resveratrol reduced markers of inflammation and oxidation in humans. Journal Clinical Endocrinology Metabolism |
| 2008: Longevinex® activates 9-fold more genes than plain resveratrol in short-term study; would require life-long calorie-restricted diet or intake of plain resveratrol to produce same effect; switches 677 of 832 longevity genes in same direction as calorie restricted diet. Experimental Gerontology 2008 | 2010: Transmax (Biotivia) failed to improve cognition (thinking) in human adult subjects. American Journal Clinical Nutrition |
| 2009: Longevinex® activates sluggish white blood cells and inhibits sticky blood platelets in 30 minutes. Nutriscreen, Covina, California | 2010: Transmax (Biotivia) 4000 mg induced diarrhea in 6 of 8 subjects; indication of emodin content. Clinical Pharmacokinetics |
| 2009: Longevinex® found to improve five measures of vision in 80-year old man as first example of molecular medicine in ophthalmology. Optometry | |
| 2010: Longevinex® turns mortal heart attacks in lab rats into non-mortal heart attacks. Potentially works more reliably than aspirin. Canadian Journal Physiology & Pharmacology | |
| 2010: Longevinex® reduces cholesterol, improves circulation in rabbits. Molecular &Cellular Biochemistry | |
| 2010: Longevinex® abolishes first sign of atherosclerosis (flow-mediated dilatation) in human trial; lowers insulin levels. Kansai Medical University, Osaka, Japan – to be presented at Japanese Circulation Society 2011 | |
| 2010: Longevinex® exerts far more action over genome (library of human genes) and improves circulation in excised rat heart following heart attack than plain resveratrol; first microRNA study of resveratrol dietary supplement. PLoS ONE in press | |
| 2010: Longevinex® exhibits first L-shaped risk curve ever recorded in biology. Exhibits no cytotoxity (cell killing) up to 7000 mg human equivalent dose in lab animals up to 90-days. Experimental & Clinical Cardiology | |
Posted in Longevinex
Add comments »